These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20732868)

  • 1. Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study.
    Metra M; Teerlink JR; Felker GM; Greenberg BH; Filippatos G; Ponikowski P; Teichman SL; Unemori E; Voors AA; Weatherley BD; Cotter G
    Eur J Heart Fail; 2010 Oct; 12(10):1130-9. PubMed ID: 20732868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
    Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld LR; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin TM; Metra M;
    Lancet; 2013 Jan; 381(9860):29-39. PubMed ID: 23141816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial.
    Filippatos G; Teerlink JR; Farmakis D; Cotter G; Davison BA; Felker GM; Greenberg BH; Hua T; Ponikowski P; Severin T; Unemori E; Voors AA; Metra M
    Eur Heart J; 2014 Apr; 35(16):1041-50. PubMed ID: 24316514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies.
    Davison BA; Metra M; Cotter G; Massie BM; Cleland JGF; Dittrich HC; Edwards C; Filippatos G; Givertz MM; Greenberg B; Ponikowski P; Voors AA; O'Connor CM; Teerlink JR;
    JACC Heart Fail; 2015 May; 3(5):395-403. PubMed ID: 25951761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
    Teerlink JR; Voors AA; Ponikowski P; Pang PS; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Gimpelewicz C; Boer-Martins L; Wernsing M; Hua TA; Severin T; Metra M
    Eur J Heart Fail; 2017 Jun; 19(6):800-809. PubMed ID: 28452195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study.
    Meyer S; Teerlink JR; Metra M; Ponikowski P; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Hua TA; Severin T; Qian M; Voors AA
    Clin Res Cardiol; 2017 Apr; 106(4):280-292. PubMed ID: 27838739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study.
    Cotter G; Metra M; Davison BA; Senger S; Bourge RC; Cleland JG; Jondeau G; Krum H; O'Connor CM; Parker JD; Torre-Amione G; van Veldhuisen DJ; Milo O; Kobrin I; Rainisio M; McMurray JJ; Teerlink JR;
    Eur J Heart Fail; 2014 Dec; 16(12):1362-71. PubMed ID: 25371147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study.
    Metra M; Cleland JG; Weatherley BD; Dittrich HC; Givertz MM; Massie BM; O'Connor CM; Ponikowski P; Teerlink JR; Voors AA; Cotter G
    Eur J Heart Fail; 2010 May; 12(5):499-507. PubMed ID: 20228387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early worsening heart failure in patients admitted with acute heart failure--a new outcome measure associated with long-term prognosis?
    Weatherley BD; Milo-Cotter O; Felker GM; Uriel N; Kaluski E; Vered Z; O'Connor CM; Adams KF; Cotter G
    Fundam Clin Pharmacol; 2009 Oct; 23(5):633-9. PubMed ID: 19656213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX-AHF-EU.
    Maggioni AP; López-Sendón J; Nielsen OW; Hallén J; Aalamian-Mattheis M; Wang Y; Ertl G
    Eur J Heart Fail; 2019 Mar; 21(3):322-333. PubMed ID: 30604559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of the RELAXin in acute heart failure study.
    Ponikowski P; Metra M; Teerlink JR; Unemori E; Felker GM; Voors AA; Filippatos G; Greenberg B; Teichman SL; Severin T; Mueller-Velten G; Cotter G; Davison BA
    Am Heart J; 2012 Feb; 163(2):149-55.e1. PubMed ID: 22305830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcome.
    Torre-Amione G; Milo-Cotter O; Kaluski E; Perchenet L; Kobrin I; Frey A; Rund MM; Weatherley BD; Cotter G
    J Card Fail; 2009 Oct; 15(8):639-44. PubMed ID: 19786251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.
    Teerlink JR; Metra M; Felker GM; Ponikowski P; Voors AA; Weatherley BD; Marmor A; Katz A; Grzybowski J; Unemori E; Teichman SL; Cotter G
    Lancet; 2009 Apr; 373(9673):1429-39. PubMed ID: 19329178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-hospital worsening heart failure in patients admitted for acute heart failure.
    Carubelli V; Cotter G; Davison B; Gishe J; Senger S; Bonadei I; Gorga E; Lazzarini V; Lombardi C; Metra M
    Int J Cardiol; 2016 Dec; 225():353-361. PubMed ID: 27756041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study.
    Cotter G; Voors AA; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Milo O; Hua TA; Qian M; Severin TM; Teerlink JR; Metra M; Davison BA
    Eur J Heart Fail; 2015 Nov; 17(11):1133-43. PubMed ID: 26333529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes.
    Cotter G; Metra M; Weatherley BD; Dittrich HC; Massie BM; Ponikowski P; Bloomfield DM; O'Connor CM
    Cardiology; 2010; 115(1):29-36. PubMed ID: 19844102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study.
    Mebazaa A; Pang PS; Tavares M; Collins SP; Storrow AB; Laribi S; Andre S; Mark Courtney D; Hasa J; Spinar J; Masip J; Frank Peacock W; Sliwa K; Gayat E; Filippatos G; Cleland JG; Gheorghiade M
    Eur Heart J; 2010 Apr; 31(7):832-41. PubMed ID: 19906690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Worsening heart failure in 'real-world' clinical practice: predictors and prognostic impact.
    AlFaleh H; Elasfar AA; Ullah A; AlHabib KF; Hersi A; Mimish L; Almasood A; Al Ghamdi S; Ghabashi A; Malik A; Hussein GA; Al-Murayeh M; Abuosa A; Al Habeeb W; Kashour T
    Eur J Heart Fail; 2017 Aug; 19(8):987-995. PubMed ID: 27071748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
    Davison BA; Metra M; Senger S; Edwards C; Milo O; Bloomfield DM; Cleland JG; Dittrich HC; Givertz MM; O'Connor CM; Massie BM; Ponikowski P; Teerlink JR; Voors AA; Cotter G
    Eur J Heart Fail; 2016 Aug; 18(8):1041-50. PubMed ID: 27114058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.
    Metra M; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld L; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Prescott MF; Edwards C; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin T; Teerlink JR;
    J Am Coll Cardiol; 2013 Jan; 61(2):196-206. PubMed ID: 23273292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.